Veery Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Sell
308
-2
-0.6% -$2.04K 0.1% 63
2026
Q1
$285K Sell
310
-1
-0.3% -$1.01K 0.09% 67
2025
Q4
$334K Buy
311
+1
+0.3% +$956 0.1% 62
2025
Q3
$237K Hold
310
0.07% 80
2025
Q2
$242K Sell
310
-8
-3% -$6.22K 0.08% 77
2025
Q1
$263K Sell
318
-10
-3% -$8.32K 0.1% 66
2024
Q4
$253K Buy
328
+5
+2% +$4.14K 0.1% 68
2024
Q3
$286K Sell
323
-13
-4% -$11.7K 0.11% 67
2024
Q2
$304K Sell
336
-2
-0.6% -$1.6K 0.12% 71
2024
Q1
$263K Sell
338
-15
-4% -$10.7K 0.11% 79
2023
Q4
$206K Buy
+353
New +$206K 0.09% 86

Other funds holding LLY

Veery Capital's LLY Position: Q2 2026 in Review

Veery Capital reduced its Eli Lilly (LLY) stake by 0.65% in Q2 2026, selling an estimated $2.04K and leaving 308 shares worth $369K. The position accounts for 0.1% of the portfolio, ranked #63.

Veery Capital first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Veery Capital held 308 shares of Eli Lilly worth $369K as of Q2 2026.
  • Veery Capital sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.1% of Veery Capital's portfolio in Q2 2026, its #63 holding.
  • Veery Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.